Studies
Study Evaluating Metastatic Castrate Resistant Prostate Cancer Treatment Using 177Lu-PNT2002 PSMA Therapy After Second-line Hormonal Treatment
Cancer
Radiology
Prostate Cancer
Adult Subjects
Male Subjects
The purpose of this study is to evaluate the efficacy and safety of \[Lu-177\]-PNT2002 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with androgen receptor axis-targeted therapy (ARAT).
A phase 0 first-in-human clinical trial of [203Pb]VMT-α-NET SPECT/CT for somatostatin receptor imaging of neuroendocrine tumors
Cancer
Radiology
Neuroendocrine Tumors
Adult Subjects
Female Subjects
Male Subjects
This is a first in man study to determine if \[203Pb\]VMT-α-NET identifies neuroendocrine tumors with SPECT/CT. This is the first step to testing \[212Pb\]-based alpha radiation therapy in neuroendocrine therapy.